David M. Knott Jr’s Xeris Biopharma Holdings XERS Stock Holding History

David M. Knott Jr’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.15M	Buy	1,060,000 +90,000	+9%	+$597K	3.66%	6
2025 Q4	$7.61M	Sell	970,000 -45,000	-4%	-$354K	3.53%	5
2025 Q3	$8.26M	Sell	1,015,000 -45,000	-4%	-$299K	3.33%	6
2025 Q2	$4.95M	Sell	1,060,000 -50,000	-5%	-$229K	2.24%	7
2025 Q1	$6.09M	Buy	1,110,000 +110,000	+11%	+$444K	2.88%	7
2024 Q4	$3.39M	Hold	1,000,000	–	–	1.23%	15
2024 Q3	$2.85M	Buy	1,000,000 +180,000	+22%	+$462K	1%	22
2024 Q2	$1.84M	Buy	820,000 +220,000	+37%	+$443K	0.74%	29
2024 Q1	$1.33M	Buy	600,000 +212,090	+55%	+$549K	0.47%	37
2023 Q4	$912K	Buy	+387,910	New	+$716K	0.35%	34

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

David M. Knott Jr's XERS Position: Q1 2026 in Review

David M. Knott Jr increased its Xeris Biopharma Holdings (XERS) stake by 9.3% in Q1 2026, buying an estimated $597K and bringing the position to 1,060,000 shares worth $6.15M. The position accounts for 3.66% of the portfolio, ranked #6.

David M. Knott Jr first reported a position in XERS in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.26M in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

David M. Knott Jr held 1,060,000 shares of Xeris Biopharma Holdings worth $6.15M as of Q1 2026.
David M. Knott Jr bought 90,000 Xeris Biopharma Holdings shares in Q1 2026, an estimated $597K.
Xeris Biopharma Holdings made up 3.66% of David M. Knott Jr's portfolio in Q1 2026, its #6 holding.
David M. Knott Jr first reported a position in Xeris Biopharma Holdings in Q4 2023 and has held it in 10 quarters since.
David M. Knott Jr's Xeris Biopharma Holdings position peaked at $8.26M in Q3 2025.
237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on David M. Knott Jr's 13F filing for Q1 2026, filed 14 May 2026.